Long Term Evaluation of Sevelamer HCl vs. Calcium-based Phosphate Binder in the Treatment of Hyperphosphatemia in Hemodialysis Patients

• Status: Completed
• Trial end date: 2009-06-01

Summary

The study is designed to compare sevelamer vs. calcium-based phosphate binder in hemodialysis patients to achieve full-scale of medical care, including reduction of atherosclerotic risk factors, reduction of vascular access reconstruction rate, and pharmacoeconomic analysis.

• Phase: Phase 4

Details

• Lead Sponsor: Chugai Pharma Taiwan
• Treatments: Calcium; Calcium acetate; Calcium Carbonate; Calcium, Dietary; Sevelamer